| Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data CR Lee, JA Goldstein, JA Pieper Pharmacogenetics and genomics 12 (3), 251-263, 2002 | 909 | 2002 |
| Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis KF Adams, JH Patterson, WA Gattis, CM O’Connor, CR Lee, TA Schwartz, ... Journal of the American College of Cardiology 46 (3), 497-504, 2005 | 344 | 2005 |
| Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice D Panigrahy, ML Edin, CR Lee, S Huang, DR Bielenberg, CE Butterfield, ... The Journal of clinical investigation 122 (1), 178-191, 2012 | 312 | 2012 |
| Vasopressin: a new target for the treatment of heart failure CR Lee, ML Watkins, JH Patterson, W Gattis, CM O’Connor, ... American heart journal 146 (1), 9-18, 2003 | 298 | 2003 |
| Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention LH Cavallari, CR Lee, AL Beitelshees, RM Cooper-DeHoff, JD Duarte, ... JACC: Cardiovascular Interventions 11 (2), 181-191, 2018 | 263 | 2018 |
| Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory Drugs KN Theken, CR Lee, L Gong, KE Caudle, CM Formea, A Gaedigk, ... Clinical Pharmacology & Therapeutics 108 (2), 191-200, 2020 | 254 | 2020 |
| Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function JM Seubert, CJ Sinal, J Graves, LM DeGraff, JA Bradbury, CR Lee, ... Circulation research 99 (4), 442-450, 2006 | 236 | 2006 |
| Genetic variation in soluble epoxide hydrolase ( EPHX2 ) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study CR Lee, KE North, MS Bray, M Fornage, JM Seubert, JW Newman, ... Human molecular genetics 15 (10), 1640-1649, 2006 | 230 | 2006 |
| β1-adrenergic receptor polymorphisms and left ventricular remodeling changes in response to β-blocker therapy SG Terra, KK Hamilton, DF Pauly, CR Lee, JH Patterson, KF Adams, ... Pharmacogenetics and genomics 15 (4), 227-234, 2005 | 216 | 2005 |
| Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update CR Lee, JA Luzum, K Sangkuhl, RS Gammal, MS Sabatine, CM Stein, ... Clinical pharmacology & therapeutics 112 (5), 959-967, 2022 | 210 | 2022 |
| Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation Y Deng, KN Theken, CR Lee Journal of molecular and cellular cardiology 48 (2), 331-341, 2010 | 201 | 2010 |
| β‐Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure SG Terra, DF Pauly, CR Lee, JH Patterson, KF Adams Jr, RS Schofield, ... Clinical Pharmacology & Therapeutics 77 (3), 127-137, 2005 | 161 | 2005 |
| Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-α via MAPK and PI3K/Akt signaling pathways S Yang, L Lin, JX Chen, CR Lee, JM Seubert, Y Wang, H Wang, ZR Chao, ... American Journal of Physiology-Heart and Circulatory Physiology 293 (1 …, 2007 | 157 | 2007 |
| Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension-induced renal injury in mice CR Lee, JD Imig, ML Edin, J Foley, LM DeGraff, JA Bradbury, JP Graves, ... The FASEB Journal 24 (10), 3770, 2010 | 154 | 2010 |
| Epoxyeicosanoids promote organ and tissue regeneration D Panigrahy, BT Kalish, S Huang, DR Bielenberg, HD Le, J Yang, ... Proceedings of the National Academy of Sciences 110 (33), 13528-13533, 2013 | 153 | 2013 |
| Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice Y Deng, ML Edin, KN Theken, RN Schuck, GP Flake, MA Kannon, ... The FASEB Journal 25 (2), 703, 2011 | 145 | 2011 |
| Activation of the acute inflammatory response alters cytochrome P450 expression and eicosanoid metabolism KN Theken, Y Deng, MA Kannon, TM Miller, SM Poloyac, CR Lee Drug metabolism and disposition 39 (1), 22-29, 2011 | 142 | 2011 |
| Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart ML Edin, ZJ Wang, JA Bradbury, JP Graves, FB Lih, LM DeGraff, JF Foley, ... The FASEB Journal 25 (10), 3436, 2011 | 138 | 2011 |
| Tolbutamide, flurbiprofen, and losartan as probes of CYP2C9 activity in humans CR Lee, JA Pieper, AL Hinderliter, RF Frye, JA Blaisdell, JA Goldstein The Journal of Clinical Pharmacology 43 (1), 84-91, 2003 | 138 | 2003 |
| Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations KJ Ellis, GA Stouffer, HL McLeod, CR Lee Pharmacogenomics 10 (11), 1799-1817, 2009 | 134 | 2009 |
Darryl ZeldinNational Institutes of HealthVerified email at niehs.nih.gov
